Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.90
+0.02 (0.12%)
Aug 5, 2026, 2:56 PM EDT - Market open
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $875.9 million as of August 5, 2026. Its market cap has increased by 56.13% in one year.
Market Cap
875.90M
Enterprise Value
520.70M
1-Year Change
56.13%
Ranking
Category
Stock Price
$16.90
ChartMarket Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $875.90M, an increase of 18.25%. That is a compound annual growth rate of 1.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 875.90M | -7.62% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 954.90M |
| Sana Biotechnology | 953.68M |
| Janux Therapeutics | 934.28M |
| Omeros | 909.03M |
| Odyssey Therapeutics | 868.03M |
| Arbutus Biopharma | 861.26M |
| Annexon | 860.17M |
| Geron | 821.15M |